4th Quarter - Report

AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS for AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS

Firm
Client
Income
—
Expenses
$60,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

In support of Repeal of the Protecting Seniors Access to Medicare Act to repeal the Medicare Independent Payment Advisory Board (S 260/HR 849)

LobbyistCovered position, as disclosed
SANDRA MARIE GUENTHER —
JEANNE TUERK —
ADAM JOHN WALASZEK —
KARIN WITTICH —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 849 (115th)

Alcohol and Drug Abuse ALC

Prescription Drug Abuse Prevention - sharing the association's efforts to educate our members

LobbyistCovered position, as disclosed
SANDRA MARIE GUENTHER —
JEANNE TUERK —
ADAM JOHN WALASZEK —
KARIN WITTICH —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Taxation/Internal Revenue Code TAX

In support of the Protect Medical Innovation Act of 2017 (S 108/HR 184) - to repeal the medical device excise tax Advocating on elements of the comprehensive tax reform bill (HR 1). Specifically advocating that OMS practices qualify for the bill's full benefits provided to pass through corporations, repealing the individual and corporate AMT, retaining student loan tax benefits, supporting the House-passed bill's maximum expensing limits, supporting the Senate-passed bill's 100% expensing of qualified property, supporting the Senate-passed bill's recovery period for determining the depreciation deduction for non-residential property, and repealing the medical device tax.

LobbyistCovered position, as disclosed
SANDRA MARIE GUENTHER —
JEANNE TUERK —
ADAM JOHN WALASZEK —
KARIN WITTICH —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1 (115th), H.R. 184 (115th)

Health Issues HCR

In support of the RAISE Health Benefits Act (HR 1204) - expanding the use of FSAs In support of the Health Savings Act (HR 35) - expanding the use of HSAs In support of the Protecting Access to Care Act (HR 1215) - medical malpractice reform Comments to HHS regarding their draft department Strategic Plan for FY 2018-2022

LobbyistCovered position, as disclosed
SANDRA MARIE GUENTHER —
JEANNE TUERK —
ADAM JOHN WALASZEK —
KARIN WITTICH —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 1204 (115th), H.R. 1215 (115th), H.R. 35 (115th)

Insurance INS

In support of the Competitive Health Insurance Reform Act of 2017 (HR 372) - antitrust reform

LobbyistCovered position, as disclosed
SANDRA MARIE GUENTHER —
JEANNE TUERK —
ADAM JOHN WALASZEK —
KARIN WITTICH —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 372 (115th)

Education EDU

In support of the Student Loan Refinancing Act (HR 1614) - would allow borrowers to refinance federal student loans In support of Employer Participation in Student Loan Assistance Act (HR 795) - would allow employers to receive a tax deduction for contributing to an employees student loan debt Also support the introduction of legislation that would: Allow interest free forbearance and/or deferment for loans in the internship/residency status of either payment delay option (HR 4001) Expand the student loan interest deduction Provide for scholarships for students going to practice medicine and dentistry in rural areas (HR 2574)

LobbyistCovered position, as disclosed
SANDRA MARIE GUENTHER —
JEANNE TUERK —
ADAM JOHN WALASZEK —
KARIN WITTICH —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1614 (115th), H.R. 4001 (115th), H.R. 795 (115th), H.R. 2574 (115th)

Medical/Disease Research/Clinical Labs MED

Advocating in support of increased NIH funding in the FY 2018 Labor-HHS-Education Appropriations bill.

LobbyistCovered position, as disclosed
SANDRA MARIE GUENTHER —
JEANNE TUERK —
ADAM JOHN WALASZEK —
KARIN WITTICH —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.